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Summary
The RIG-I/Mda5 sensors recognize RNA virus infection through their ability to bind intracellular viral RNA and trigger the host antiviral response. In the present study, we investigated the role of linear ubiquitin assembly complex (LUBAC) -consisting of the E3 ligases HOIL-1L, HOIP, and the accessory protein SHARPIN-in the differential regulation of the RIG-I pathway. LUBAC downregulated virus-mediated interferon (IFN) induction by targeting NEMO for linear ubiquitination. Linear ubiquitinated NEMO associated with TRAF3 and disrupted the MAVS-TRAF3 complex, leading to the inhibition of IFN activation while stimulating NF-κB dependent signaling. In SHARPIN deficient MEFs, vesicular stomatitis virus replication was decreased as a consequence of increased IFN production. Linear ubiquitination thus switches NEMO from a positive to a negative regulator of RIG-I signaling that dissociates the MAVS-TRAF3 complex and contributes to the negative regulation of the IFN antiviral response.
INTRODUCTION
The innate immune response represents the first line of defense against microbial pathogens and results in the production of immunomodulatory cytokines and the mobilization of innate immune cells. Central to the early host defense against viral infection is the production of interferons (IFN) and the synthesis of antiviral IFN stimulated genes (ISGs) that contain virus dissemination and activate the adaptive immune response Sadler and Williams, 2008; Sen and Sarkar, 2007) . Viral nucleic acids represent pathogen-associated molecular patterns (PAMPs) that are recognized by Pattern Recognition Receptors (PRRs) to trigger the type I IFN -IFNα and IFNβ -production (Belgnaoui et al., 2011; Loo and Gale, 2011; Takeuchi and Akira, 2010; Yoneyama and Fujita, 2010) . PRRs responsible for the detection of RNA viruses (and some DNA viruses) include both the membrane-bound Toll-like receptors (TLRs) and cytosolic sensors, such as retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) (Belgnaoui et al., 2011; Beutler, 2009; Kumar et al., 2011; Loo and Gale, 2011; Takeuchi and Akira, 2010; Wilkins and Gale, 2010; Yoneyama and Fujita, 2010) .
Early viral RNA replicative intermediates are mainly detected by RIG-I or Mda5 (melanoma differentiation-associated gene 5) -two characterized cytosolic viral RNA receptors belonging to the DExD/H box RNA helicase family Yoneyama et al., 2004) . The functions of RIG-I and Mda5 are non-redundant as RIG-I specifically detects intracellular double-stranded (ds) viral RNA bearing 5′ triphosphate and panhandle structures (Rehwinkel et al., 2010; Schlee and Hartmann, 2010; Schlee et al., 2009; Yoneyama and Fujita, 2008) , leading to RIG-I interaction with the downstream adapter protein MAVS (also known as Cardif/IPS-1/VISA) (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) ; Mda5 recognizes dsRNA structures such as synthetic poly (I:C) (>2kb) and also signals through MAVS.
Strategically localized at the outer mitochondrial membrane or on peroxisomes, MAVS assembles a signaling platform that triggers the IFN antiviral response, via activation of the transcription factors NF-κB and IFN regulator factors (IRF)-3 and -7 (Belgnaoui et al., 2011; Dixit et al., 2010; Scott, 2010) . Crucial to MAVS complex formation and downstream signaling is the recruitment of the Tumor Necrosis Factor (TNF) Receptor-Associated Factors (TRAFs), a family of cytoplasmic signaling adapter proteins (Hacker et al., 2011) . Several TRAF family 4 members -TRAF-2, -3, -5 and -6 -directly bind to MAVS via TRAF-interacting motifs (TIM) in the N-and C-terminal regions of MAVS Saha et al., 2006; Tang and Wang, 2010; Xu et al., 2005) . Interaction of MAVS with TRAF-2 or -6 is involved in IKK-dependent NF-κB activation (Xu et al., 2005) , whereas TRAF3 is specifically involved in TBK1-dependent IRF-3 or -7 activation Saha et al., 2006) .
In addition to the adapters, kinases and accessory proteins of the MAVS complex, the NF-κB modulator protein NEMO (IKKγ) also interfaces with the RIG-I pathway, and forms a regulatory bridge between the canonical IKKα/β kinases and the non-canonical kinases TBK1/IKKε via the TANK adapter (Chariot et al., 2002; Zhao et al., 2007) . NEMO activity is regulated by numerous post-translational modifications, including ubiquitination, phosphorylation and sumoylation (Liu and Chen, 2011; Sebban et al., 2006) . Multiple ubiquitination signals have been identifiedmono, multiple-or polyubiquitination -that control protein fate and turnover (Bhoj and Chen, 2009; Dikic and Dotsch, 2009; Ikeda et al., 2010; Kirisako et al., 2006; Malynn and Ma, 2010; Weissman et al., 2011) . Lys48 and Lys63 linkages are the best characterized types of polyubiquitination, with Lys48-linked polyubiquitination leading to ubiquitin-dependent degradation by the 26S proteasome (Dikic and Dotsch, 2009; Gallastegui and Groll, 2010) . In contrast, Lys63-linked ubiquitination is associated with activation of protein kinases, proteinprotein interactions, DNA repair and endocytosis (Bergink and Jentsch, 2009; Bhoj and Chen, 2009 ).
Recently, a new form of polyubiquitin chain formation was identified in association with NEMO; unlike Lys63-or Lys48-linked polyubiquitin chains that link ubiquitin moieties via a lysine residue of the previously attached ubiquitin, linear ubiquitination consists of head-to-tail linked ubiquitin moieties (Tokunaga et al., 2009) . Upon TNFα stimulation, the E3 ligase linear ubiquitin chain assembly complex (LUBAC), composed of the two RING-IBR-RING (RBR)-containing E3 ligases, HOIL-1L (also known as RBCK1 and RNF54) and HOIP (also known as ZIBRA and RNF31), mediates the formation of linear ubiquitin chains on NEMO (Tokunaga et al., 2009) , which functions to activate NF-κB signaling downstream of the TNF receptor.
LUBAC activity is also dependent on a third accessory protein SHANK-associated RH domain 5 interactor (SHARPIN) that stabilizes the E3 complex (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) .
Linear ubiquitination also modulates the RIG-I antiviral pathway but has not been reported to affect the Mda5 receptor. TRIM25, an E3 ligase that regulates RIG-I activation via Lys63-linked ubiquitination (Gack et al., 2007) , was characterized as a unique target of the LUBAC complex (Inn et al., 2011) , with linear ubiquitination of TRIM25 resulting in its proteasomal degradation.
HOIL-1L or HOIP independently mediated Lys48-linked polyubiquitination and proteasomal degradation of TRIM25 (Inn et al., 2011) .
In the present study, we demonstrate that the LUBAC complex contributes to negative regulation LUBAC activated the NF-κB promoter more than 50-fold but inhibited Sendai virus (SeV)-mediated activation of the ISRE promoter by 3-fold (Fig 1a) . To determine at what level in the pathway LUBAC blocked ISRE expression, the active CARD domain containing form of RIG-I (ΔRIG-I) (Yoneyama et al., 2004) , the Mda5 sensor, MAVS, TBK1 kinase or the active form of IRF-3 (IRF-3(5D)) were expressed in the presence or absence of LUBAC. All expression constructs resulted in a 300-to 1000-fold induction of ISRE-Luc reporter activity (Fig 1b, white bar). ISRE activation driven by Mda5, ΔRIG-I, or MAVS was inhibited more than 85% by 6 LUBAC, whereas ISRE induction by TBK1 or IRF-3(5D) was not affected by LUBAC coexpression (Fig 1b, compare black to white bars). The same expression constructs also induced ISG15 protein expression (Fig 1c, compare lanes 3 , 5, 7, 9, and 11) , and the addition of LUBAC inhibited ISG15 induction by Mda5, ΔRIG-I, or MAVS (Fig 1c, lanes 4, 6 and 8 ), but not by TBK1 or IRF-3 (5D) (Fig 1c, lanes 10 and 12) . To confirm the inhibitory effect of LUBAC on IFN signaling, expression of HOIL-1L was knocked down by small interfering RNA (siRNA) in A549 cells, followed by SeV challenge for 4, 8 and 12h. IRF-3 phosphorylation (4h) and subsequent degradation (12h) was increased in cells with decreased levels of HOIL-1L (Fig 1d) .
Inhibition of HOIL-1L expression also led to an increase in ISRE promoter activation by Mda5, ΔRIG-I, or MAVS, but not by TBK1 or IRF-3 (5D) (Fig 1e) . Similar experiments using the TLR3 and TLR4 adaptor protein TRIF demonstrated that LUBAC did not affect MAVSindependent ISRE promoter activation (data not shown). These results indicate that LUBAC inhibits the IFN antiviral response downstream of MAVS and upstream of TBK1.
Linear ubiquitination of NEMO inhibits IFN induction. The association of the IKK adapter
NEMO and the TBK1 adapter TANK coordinately regulates NF-κB and IRF-3 signaling downstream of RIG-I (Chariot et al., 2002; Zhao et al., 2007) . To investigate whether LUBACmediated linear ubiquitination of NEMO was involved in the control of type I IFN signaling, we generated NEMO chimeric constructs fused at their C-terminus with linear ubiquitin chains of variable sizes, consisting of 1, 2 or 4 linear ubiquitin moieties, termed NEMO-Ub1, NEMO-Ub2 and NEMO-Ub4, respectively. The different NEMO-Ub chimeras stimulated NF-κB reporter gene activity without any additional stimulation, whereas unmodified wild type NEMO (wt-NEMO) failed to activate the NF-κB reporter gene (Fig 2a) . When the chimeric constructs were tested with the ISRE promoter after SeV infection or expression of Mda5, ΔRIG-I, MAVS, TBK1 or IRF-3(5D), neither wt-NEMO nor NEMO-Ub chimeras activated the ISRE promoter alone; in contrast NEMO-Ub2 and NEMO-Ub4 inhibited SeV, Mda5, ΔRIG-I or MAVS-driven promoter activity by >75%, compared to wt-NEMO or NEMO-Ub1 (Fig 2b and 2c) . Similar to the results obtained with LUBAC, the NEMO-Ub constructs did not inhibit TBK1-or IRF-3(5D)-driven ISRE activity. MAVS-independent activation of the ISRE promoter by TRIF was not affected by the different NEMO-Ub constructs (data not shown). Furthermore, NEMO-Ub2 7 inhibited expression of various ISGs -ISG15, ISG56 and RIG-I -whereas, wt-NEMO or NEMOUb1 had no effect on ISG expression (Fig 2d, compare lane 5, 8 and 11, top, second and third panels). Interestingly, NEMO-Ub2 also failed to inhibit ISG expression after IFNα treatment (Fig 2d, lane 12) , suggesting that the inhibition of the type I IFN signaling pathway occurred at an early stage of signaling, prior to IFN release.
Linear ubiquitinated NEMO interacts with TRAF3. Because both TRAF3 and NEMO are positive regulators of type I IFN signaling downstream of MAVS, we investigated the possibility that linear ubiquitination of NEMO regulated the formation of the MAVS-TRAF3 complex. In co-precipitation experiments, TRAF3 co-precipitated with NEMO-Ub2, weakly with NEMOUb1 (Fig 3a, compare lane 4 to 3, top panel) and not with wt-NEMO (Fig 3a, lane 2, top panel).
Next, NEMO and TRAF3 were expressed in the presence or absence of LUBAC. NEMO alone did not interact with TRAF3, but the addition of LUBAC led to the formation of the NEMO-TRAF3 complex (Fig 3b, compare lane 5 to 6, second panel). In the same experiment, using a NEMO specific antibody, modified forms of NEMO were detected in the presence of LUBAC, thus suggesting that linear ubiquitinated NEMO interacted with TRAF3 (Fig 3b, lane 6, top panel). To demonstrate that LUBAC E3 ligase complex formation was required for this interaction, HOIL-1L and/or HOIP were expressed in the presence of TRAF3 and NEMO (Fig   3c) . A NEMO-TRAF3 interaction was readily detected when both LUBAC components were present, but not when individual components were expressed (Fig 3c, compare lane 7 to lanes 8 and 9), thus demonstrating that NEMO-TRAF3 interaction was dependent on the presence of the LUBAC complex.
Linear ubiquitinated NEMO competes with MAVS for TRAF3 binding. To examine whether linear ubiquitination of NEMO affected IFN signaling at the level of MAVS-TRAF3 interaction, MAVS-TRAF3 association was determined in the presence of LUBAC and/or NEMO.
Expression of MAVS led to an interaction with TRAF3 (Fig 4a, lane 4) ; when individually expressed, NEMO and LUBAC co-expression modestly disrupted this interaction, by 2.4 and 1.7 fold respectively (59% and 41%, respectively) (Fig 4a, lane 5 and 7) , but in the presence of both LUBAC and NEMO, the MAVS-TRAF3 complex was decreased more than 5-fold (81%) (Fig 4a, lane 8) . Conversely, the LUBAC-induced TRAF3-NEMO interaction was disrupted in the presence of MAVS (Fig 4b, compare lane 8 and 9 ) and the reciprocal co-precipitation generated similar results (Fig 4c) . To determine whether linear ubiquitinated NEMO and MAVS compete for TRAF3 binding, NEMO was precipitated in the presence of constant amounts of LUBAC and TRAF3, but increasing amounts of MAVS. Increasing MAVS disrupted the LUBAC induced NEMO-TRAF3 complex in a dose dependent manner (Fig 4d) . Taken together, these results indicate that the MAVS-TRAF3 interaction is disrupted by linear ubiquitinated NEMO.
Increased antiviral response and decreased VSV replication in cpdm MEFs. To test the endogenous role of linear ubiquitination in the RIG-I pathway, cpdm MEFs, deficient in the accessory protein SHARPIN that functions to stabilize the LUBAC complex (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) were used to measure replication of a recombinant VSV expressing green fluorescent protein (VSV-GFP) (Fig 5a) . In cpdm MEFs, at 24 and 48h after VSV infection, fewer cells were positive for GFP fluorescence, compared to wt MEFs (~ 70% GFP-positive wt MEFs, compared to ~40% GFP-positive cpdm MEFs) (Fig 5b) .
Additionally, VSV replicated in cpdm compared to wt MEFs, as reflected by VSV glycoprotein (VSV-G) expression (Fig 5c, second panel) . Furthermore, an enhanced antiviral response was observed in cpdm MEFs compared to wt MEFs following VSV infection, as reflected by an increase in IFNβ promoter activity (~200-fold induction in wt MEFs compared to ~600-fold increase in cpdm MEFs) and IFNα4 promoter (~50-fold induction in wt MEFs compared to ~250-fold in cpdm MEFs) (Fig 5d) . RIG-I protein expression was also increased in cpdm MEFs, thus demonstrating a stronger induction of IFN production (Fig 5c, top panel) . Because NF-κB activation by TNFα was shown to be impaired in cpdm MEFs (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) , we also examined whether NF-κB activation was defective in the context of VSV infection. NF-κB and IL6 promoter activation were attenuated in cpdm MEFs after VSV infection (from ~20-fold to ~ 5-fold and from ~ 9-fold to ~3-fold respectively) (Fig   5e) . Because SHARPIN was shown to have an anti-apoptotic role upon TNFα activation (Gerlach et al., 2011; Ikeda et al., 2011) , the level of apoptosis in wt and cpdm MEFs was assessed after virus infection. An increase in apoptosis, as measured by Annexin V/ propidium iodide (PI) positive cells (45% in cpdm MEFs compared to 15% in wt MEFs), and an accumulation of cleaved caspase 3 in cpdm compared to wt MEFs were detected (Fig 5f and 5g) , demonstrating that SHARPIN deficiency rendered the cells more sensitive to virus-induced cell death.
Linear ubiquitinated NEMO interacts with TRAF3 and dissociates the MAVS-TRAF3 complex. Next, using a linear ubiquitin chain specific antibody (Tokunaga et al., 2009) , we demonstrated that endogenous NEMO was targeted for linear ubiquitination after VSV infection (Fig 6a) . In wt MEFs, NEMO was linearly ubiquitinated 48h after infection (Fig 6a, top panel, lane 5), concomitant with its interaction with TRAF3 (Fig 6a, second panel, lane 5) . In contrast, NEMO did not undergo linear ubiquitination in cpdm MEFs and did not bind TRAF3 (Fig 6a, lanes 6-10 top and second panel). The reciprocal co-immunoprecipiation experiment in which TRAF3 was immunoprecipitated, confirmed the strong interaction between TRAF3 and NEMO at 48h in wt MEFs (Fig 6b) . This association was decreased by more than 6-fold in cpdm MEFs, indicating that TRAF3-NEMO association was enhanced in a linear ubiquitin-dependent manner (Fig 6b, compare The expression of antiviral IFN stimulated genes -IRF7, DDX58 (RIG-I) and OAS1 were also highly induced in cpdm MEFs (Fig 7a, black bars) after virus infection, compared to wt MEFs (white bars), due to intact signalling as a consequence of MAVS-TRAF3 complex formation in cpdm MEFs (Fig 6c) . IRF7 mRNA levels peaked at ~150-fold in cpdm MEFs compared to ~15-fold in wt MEFs; similarly, DDX58 peaked at ~13-fold and OAS1 peaked at ~250-fold; the values in wt MEFs were ~ 3-fold and ~30-fold respectively. By ELISA, a 3-fold increase in IFNα and IFNβ release into the supernatant of cpdm cells was detected compared to wt MEFs (Fig 7b) . Strikingly, VSV infection of cpdm MEFs failed to induce IL6 promoter (Fig 7c, black   bars) , illustrating the functional impact of NF-κB inhibition on inflammatory cytokine gene expression. IL6 release post-VSV infection was also 3-fold lower in cpdm compared to wt MEFs (Fig 7d) . Altogether, these results demonstrate that linear ubiquitination of NEMO following virus infection facilitates the formation of a NEMO-TRAF3 heterodimer, that sequesters TRAF3 away from the MAVS complex and limits RIG-I dependent signaling (Fig 7e) . Linear ubiquitination of NEMO thus negatively regulates production of type I IFN and multiple ISGs, while positively regulating activation of NF-κB and inflammatory gene expression.
DISCUSSION
In the present study, we demonstrate an essential role for LUBAC-mediated linear ubiquitination of NEMO in the negative regulation of the RIG-I antiviral pathway through sequestration of TRAF3 from the MAVS adapter. LUBAC and NEMO-Ub constructs inhibited RIG-I signaling downstream of MAVS and upstream of TBK1; linearly ubiquitinated NEMO interacted physically with TRAF3, and disrupted the MAVS-TRAF3 complex, thus providing a mechanistic explanation for the downregulation of RIG-I signaling. Using SHARPIN deficient cpdm MEFs, we observed on the one hand, an increased and prolonged antiviral response, while on the other hand, an impaired NF-κB activation, indicating that linear ubiquitination is required for NF-κB activation downstream of RIG-I. Interestingly, an increase in apoptotic cell death was also detected in SHARPIN-deficient cpdm MEFs after VSV infection, potentially attributable to the absence of the anti-apoptotic activity of NF-κB.
These studies reveal a novel negative feedback mechanism used by host cells to regulate the IFN antiviral response. The formation of the MAVS-TRAF3 complex is a crucial step of the IFN response to RNA viruses and early after virus infection, TRAF3 acts as bridging adapter in the assembly of the active MAVS-TRAF3-TBK1 signaling complex that also includes NEMO Zeng et al., 2010) . Previously, we demonstrated the positive regulatory role of NEMO as a bridge between the canonical IKKα/β kinases and the non-canonical kinases TBK1/IKKε via the TANK adapter (Zhao et al., 2007) . Here, we show that at 24-48h postinfection, linear ubiquitination of NEMO by LUBAC facilitates its interaction with TRAF3, an association that sequesters TRAF3 away from MAVS (Fig 7e) . Linear ubiquitination thus switches NEMO from a positive mediator of RIG-I signaling to a negative regulator that dissociates the antiviral signaling complex through a competition mechanism. There are several possibilities that may explain the increased ability of linear ubiquitinated NEMO to dissociate TRAF3 from MAVS, including a direct binding of TRAF3 to linear ubiquitin chains or a high affinity of TRAF3 for the conformationally altered form of NEMO.
Regulation of RIG-I signaling through ubiquitination has been extensively studied. TRIM25 and RNF135 (REUL) activate the pathway by mediating Lys63-linked polyubiquitination of RIG-I (Gack et al., 2007; Oshiumi et al., 2010) . Conversely, inhibition of the pathway is achieved through the Lys48-linked polyubiquitination and subsequent proteasomal degradation of RIG-I and MAVS by RNF125, and TRAF3 by Triad3A (Arimoto et al., 2007; Nakhaei et al., 2009 ).
The ubiquitin editing protein A20 and several deubiquitinases such as DUBA, OTUB and CYLD also negatively regulate RIG-I signaling (Kayagaki et al., 2007; Li et al., 2010; Lin et al., 2006; Wertz et al., 2004; Zhang et al., 2008b) ; CYLD was shown to inhibit RIG-I signaling by removing Lys63-linked ubiquitin chains from both RIG-I and TBK1 (Zhang et al., 2008b) , while DUBA inhibits the pathway by cleaving Lys63 chain from TRAF3, leading to its dissociation from TBK1 (Kayagaki et al., 2007) .
These multiple non-redundant mechanisms of regulation of the early antiviral response illustrate the requirement to maintain appropriate regulatory homeostasis of the IFN pathway. Many examples of the pathological consequences of dysregulation of antiviral and inflammatory responses to pathogens exist. The IFIH1 gene encoding Mda5 has been associated with several types of autoimmune diseases such as type I diabetes, Grave's disease and systemic lupus erythematous (SLE) (Gateva et al., 2009; Smyth et al., 2006; Sutherland et al., 2007) . Activation of TLR7 and TLR9 on B cells and plasmacytoid dendritic cells by self-nucleic acid is also crucial step in SLE pathogenesis (Barrat and Coffman, 2008; Guiducci et al., 2010) . Production of TLR mediated anti-nuclear antibodies and type I interferon correlated with the severity of the disease (Banchereau and Pascual, 2006; Hahn, 1998) . Perhaps unsurprisingly, IRF7, a downstream effector of both RLR-and TLR-signaling, has been linked to SLE onset (Xu et al., 2012) . Lastly, the involvement of the ubiquitin regulatory TRIM proteins in various autoimmune and autoinflammatory disorders (including multiple sclerosis, SLE and Sjögren's syndrome) has been established (Jefferies et al., 2011) . How these negative regulatory mechanisms are disrupted in various pathological states is critical to the understanding of conditions involving chronic antiviral and inflammatory responses.
EXPERIMENTAL PROCEDURES
Plasmid construction. Plasmids encoding GFP-MAVS, MYC-MAVS, GFP-ΔRIG-I, GFP-TBK1, GFP-IRF-3(5D), ISRE-luciferase, pRLTK, FLAG-NEMO, FLAG-TRAF3, HA-Ub, MYC-HOIP and HA-HOIL-1 were previously described (Paz et al., 2009; Paz et al., 2011; Tokunaga et al., 2009; Zhao et al., 2007) . The Mda5 expression plasmid was a gift from I.
Julkunen (Siren et al., 2006) . To generate GFP-Mda5 expression plasmid, Mda5 cDNA was amplified by PCR from Mda5 expression plasmid and cloned into pEGFPc1. Flag NEMO was inserted into pMSCV puro vector (Clontech). FLAG-NEMO-Ub1, Ub2 and Ub4 were constructed by adding one ubiquitin or tandem linkage of two or four ubiquitin moieties at the Cterminus of Flag NEMO. To generate S-NEMO, S-NEMO-Ub1 and S-NEMO-Ub2 expression plasmids, the cDNA encoding S-NEMO, S-NEMO-Ub1 and S-NEMO-Ub2 were cloned into pTriEX-4 Neo vector (Novagen).
Cell culture, transfection and luciferase assay. Wt MEFs and cpdm MEFs from mice deficient in SHARPIN have been described (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) . HEK 293 and MEFs were grown in DMEM media ( expression plasmid by the calcium phosphate transfection method (Zhao et al., 2007) . At 24 h chemiluminescence detection system as recommended by the manufacturer (PerkinElmer).
Densitometry analysis were performed using ImageJ software (NIH Windows version)
Protein-protein interaction analysis. For S-tag precipitation, 500 µg of whole cell lysate was incubated with 90 µl bed volume of S-protein agarose (Novagen,), rotating at 4°C for 6h, then washed 3 times with 1 ml lysis buffer (20mM Tris [pH 7.5], 150mM NaCl, 10% glycerol, 1% triton, 1mM DTT, 1mM PMSF, 40mM beta-glycerol phosphate, 1mM sodium orthovanadate, Protease inhibitor, 5mM sodium fluoride, 10 mM N-ethylmaleimide). Washed beads were eluted by resuspension in 45 µl Laemmli Sample Buffer with β-mercaptoethanol, followed by boiling for 10 minutes. Eluates were electrophoresed in a 10% SDS polyacrylamide gel and transferred onto nitrocellulose blot. The transferred blots were autoclaved for 30 minutes in water then 15 minutes dry. Blots were blocked for one hour at room temperature in 20% heat inactivated bovine calf serum-TBS-0.45% Tween then processed for immunoblot analysis with the appropriate antibodies, as described above.
For endogenous immunoprecipitation experiments in MEFs, cells were harvested and lysed in immunoprecipitation lysis buffer (20mM Tris [pH 7.0], 250mM NaCl, 3mM EDTA, 3mM EGTA, 0.5% NP-40, 1mM DTT, 1mM PMSF, 40mM beta-glycerol phosphate, 1mM sodium orthovanadate, Protease inhibitor, 5mM sodium fluoride, 10 mM N-ethylmaleimide). To detect the ubiquitinated form of NEMO, lysed cells were incubated at 95 °C for 30 min in 1% SDS in immunoprecipitation lysis buffer, and then diluted to 0.1% SDS with immunoprecipitation lysis buffer. NEMO was immunoprecipitated using an antibody against NEMO (BD pharmingen) at 4°C for 2 h, followed by incubation with protein A/G-PLUS agarose beads overnight. MAVS was immunoprecipitated using an antibody against MAVS (EMD Millipore 06-1043), TRAF3 was immunoprecipitated using an antibody against TRAF3 (Santa-Cruz, sc-6933).
Immunoprecipitates were resolved on 10% SDS-PAGE and processed for immunoblot analysis with the appropriate antibodies, as described above.
Virus production, quantification and infection. Recombinant VSV-GFP, which harbors the methionine 51 deletion in the matrix protein-coding sequence (Stojdl et al., 2003) 
